Preview

Кардиология

Расширенный поиск

Значение гипергликемии и вариабельности гликемии у пациентов с декомпенсацией хронической сердечной недостаточности в зависимости от выраженности нарушений углеводного обмена

https://doi.org/ 10.18087/cardio.2403

Полный текст:

Аннотация

В настоящем обзоре представлены данные о прогностическом значении гипергликемии и вариабельности гликемии у пациентов как с СД 2 типа, так и без ранее диагностированных нарушений углеводного обмена, госпитализированных в стационар по поводу декомпенсации ХСН. Анализируются результаты последних исследований, посвященных изучению вариабельности гликемии, стрессорной гипергликемии и влиянию их на прогноз у пациентов с декомпенсацией ХСН.

Об авторах

М. Ю. Юрьева
ГБОУ ВПО «СГМУ» МЗ РФ
Россия


И. В. Дворяшина
ГБОУ ВПО «СГМУ» МЗ РФ
Россия


Список литературы

1. Рекомендации Esc по диагностике и лечению острой и хронической сердечной недостаточности 2016. Российский кардиологический журнал. 2017; (1 (141)): 7-81 [Rekomendaczii Esc po diagnostike i lecheniyu ostroj i xronicheskoj serdechnoj nedostatochnosti 2016. Rossijskij kardiologicheskij zhurnal. 2017; (1 (141)): 7-81].

2. Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13 (6):368-78. DOI:10.1038/nrcardio. 2016.25.

3. Мареев В. Ю., Фомин И. В., Агеев Ф. Т., Арутюнов Г. П., Беграмбекова Ю. Л., Васюк Ю. А. и др. Хроническая сердечная недостаточность (ХСН). Журнал Сердечная Недостаточность. 2017;18 (1):3-40. DOI:10.18087/rhfj. 2017.1.2346 [MareevV. Yu., Fomin I. V., Ageev F. T., Arutyunov G. P., Begrambekova Yu. L., Vasyuk Yu. A. i dr. Xronicheskaya serdechnaya nedostatochnost' (XSN). Zhurnal Serdechnaya Nedostatochnost'. 2017;18 (1):3-40. DOI:10.18087/rhfj. 2017.1.2346].

4. Cowie MR, Anker SD, Cleland JGF. Improving care for patients with acute heart failure: before, during and after hospitalization. Oxford: Oxford PharmaGenesis Ltd; 2014.

5. Фомин И. В., Мареев В. Ю., Агеев Ф. Т., Бадин Ю. В., Поляков Д. С., Даниелян М. О. и др. Сахарный диабет как этиологическая причина ХСН в Европейской части Российской Федерации (Исследование ЭПОХА-ХСН, госпитальный этап). Журнал Сердечная Недостаточность. 2012;13 (1):3-8 [Fomin I. V., Mareev V. Yu., Ageev F. T., Badin Yu. V., Polyakov D. S., Danielyan M. O. i dr. Saxarny'j diabet kak e'tiologicheskaya prichina XSN v Evropejskoj chasti Rossijskoj Federaczii (Issledovanie E'POXA-XSN, gospital'ny'j e'tap). Zhurnal Serdechnaya Nedostatochnost'. 2012;13 (1):3-8].

6. Lainscak M, Doehner W, Anker SD. Metabolic disturbances in chronic heart failure: a case for the “macho" approach with testosterone?! Eur J Heart Fail. 2007;9 (1):2-3. DOI:10.1016/j. ejheart. 2006.07.006.

7. Leier CV, Haas GJ. Diabetes and heart failure: the role of thiazolidinediones in managing these partners in crime. J Am Coll Cardiol. 2007;50 (1):37-9. DOI:10.1016/j. jacc. 2007.04.026.

8. Dei Cas A, Khan SS, Butler J, Mentz RJ, Bonow RO, Avogaro A et al. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. JACC Heart Fail. 2015;3 (2):136-45. DOI:10.1016/j.jchf. 2014.08.004.

9. Flores-Le Roux JA, Comin J, Pedro-Botet J, Benaiges D, Puig-de Dou J, Chillaron JJ et al. Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study. Cardiovasc Diabetol. 2011;10:39. DOI:10.1186/1475-2840-10-39.

10. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979;59 (1):8-13.

11. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 2001;24 (9):1614-9.

12. MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29 (11):1377-85. DOI:10.1093/eurheartj/ehn153. ISSN 0022-9040. Кардиология. 2017;57(S4)

13. Dei Cas A, Fonarow GC, Gheorghiade M, Butler J. Concomitant diabetes mellitus and heart failure. Curr Probl Cardiol. 2015;40 (1):7-43. DOI:10.1016/j. cpcardiol. 2014.09.002.

14. Wang C-C, Chang H-Y, Yin W-H, Wu Y-W, Chu P-H, Wu C-C et al. TSOC-HFrEF registry: a registry of hospitalized patients with decompensated systolic heart failure: description of population and management. Acta Cardiol Sin. 2016;32 (4):400-11.

15. Targher G, Dauriz M, Laroche C, Temporelli PL, Hassanein M, Seferovic PM et al. In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19 (1):54-65. DOI:10.1002/ejhf. 679.

16. Sarma S, Mentz RJ, Kwasny MJ, Fought AJ, Huffman M, Subacius H et al. Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. Eur J Heart Fail. 2013;15 (2):194-202. DOI:10.1093/eurjhf/hfs153.

17. Aguilar D, Deswal A, Ramasubbu K, Mann DL, Bozkurt B. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol. 2010;105 (3):373-7. DOI:10.1016/j. amjcard. 2009.09.041.

18. Стронгин Л. Г., Починка И. Г., Алейник Д. Я., Чарыкова И. Н. Предикторы выживаемости больных хронической сердечной недостаточностью, страдающих сахарным диабетом 2 типа. Сахарный диабет. 2004; (4):14-8 [Strongin L. G., Pochinka I. G., Alejnik D. Ya., Chary'kova I. N. Prediktory' vy'zhivaemosti bol'ny'x xronicheskoj serdechnoj nedostatochnost'yu, stradayushhix saxarny'm diabetom 2 tipa. Saxarny'j diabet. 2004; (4):14-8].

19. Kasznicki J, Drzewoski J. Heart failure in the diabetic population - pathophysiology, diagnosis and management. Arch Med Sci. 2014;10 (3):546-56. DOI:10.5114/aoms. 2014.43748.

20. Le Corvoisier P, Bastuji-Garin S, Renaud B, Mahé I, Bergmann J-F, Perchet H et al. Functional status and co-morbidities are associated with in-hospital mortality among older patients with acute decompensated heart failure: a multicentre prospective cohort study. Age Ageing. 2015;44 (2):225-31. DOI:10.1093/ageing/afu144.

21. Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A et al. Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol. 2013;61 (8):820-9. DOI:10.1016/j. jacc. 2012.11.054.

22. Sud M, Wang X, Austin PC, Lipscombe LL, Newton GE, Tu JV et al. Presentation blood glucose and death, hospitalization, and future diabetes risk in patients with acute heart failure syndromes. Eur Heart J. 2015;36 (15):924-31. DOI:10.1093/eurheartj/ehu462.

23. Shah RV, Altman RK, Park MY, Zilinski J, Leyton-Mange J, Orencole M et al. Usefulness of hemoglobin A (1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure. AmJ Cardiol. 2012;110 (5):683-8. DOI:10.1016/j. amjcard. 2012.04.056.

24. Novack V, Pencina M, Zahger D, Fuchs L, Nevzorov R, Jotkowitz A et al. Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. PLoS ONE. 2010;5 (8):e12184. DOI: 10.1371/journal. pone. 0012184.

25. Dungan KM, Osei K, Nagaraja HN, Schuster DP, Binkley P. Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during implementation of hospital-wide initiatives. Endocr Pract. 2010;16 (6):945-51. DOI:10.4158/EP10093. OR.

26. Su G, Mi S, Tao H, Li Z, Yang H-X, Zheng H et al. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care. 2013;36 (4):1026-32. DOI:10.2337/dc12-0925.

27. Okada K, Hibi K, Gohbara M, Kataoka S, Takano K, Akiyama E et al. Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes. Cardiovasc Diabetol. 2015; 14:111. DOI: 10.1186/s12933-015-0275-3.

28. Zhang J, Li L, Zhai H, Chen H, Wang L, Li N et al. Impact of blood glucose fluctuation on endothelial dysfunction and severity of stenosis in aged acute coronary syndrome patients. Int J Clin Exp Med. 2016;9 (11):22102-9.

29. Сиволап В. Д., Капшитарь Н. И. Взаимосвязь вариабельности и уровня гликемии со структурно-функциональными показателями сердца у больных хронической сердечной недостаточностью на фоне сахарного диабета 2 типа. Sciencerise. 2016; 1 (3 (18)): 53-7. DOI:10.15587/2313-8416.2016.59329 [Sivolap V. D., Kapshitar' N. I. Vzaimosvyaz' variabel'nosti i urovnya glikemii so strukturno-funkczional'ny'mi pokazatelyami serdcza u bol'ny'x xronicheskoj serdechnoj nedostatochnost'yu na fone saxarnogo diabeta 2 tipa. Sciencerise. 2016;1 (3 (18)): 53-7. DOI: 10.15587/2313-8416.2016.59329].

30. Dungan KM, Han W, Miele A, Zeidan T, Weiland K. Determinants of the accuracy of continuous glucose monitoring in non-critically ill patients with heart failure or severe hyperglycemia. J Diabetes Sci Technol. 2012;6 (4):884-91. DOI:10.1177/193229681200600420.

31. Dungan K, Graessle K, Sagrilla C. The effect of congestive heart failure on sensor accuracy among hospitalized patients with type 2 diabetes. Diabetes Technol Ther. 2013;15 (10):817-24. DOI: 10.1089/dia. 2013.0094.

32. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27 (2):553-91.

33. Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med. 2011;124 (11):1028-35. DOI:10.1016/j. amjmed. 2011.07.011.

34. Sanon VP, Sanon S, Kanakia R, Yu H, Araj F, Oliveros R et al. Hypoglycemia from a cardiologist's perspective. Clin Cardiol. 2014;37 (8):499-504. DOI:10.1002/clc. 22288.

35. Shilo S, Berezovsky S, Friedlander Y, Sonnenblick M. Hypoglycemia in hospitalized nondiabetic older patients. J Am Geriatr Soc. 1998;46 (8):978-82.

36. Hajji R, Elleuch M, Derbali F, Kammoun N, Zribi S. Persistent hypoglycemia revealing severe heart failure. Journal of Gerontology & Geriatric Research. 2016;5 (3):303. DOI:10.4172/2167-7182.1000303.

37. Aleksandrov AA, Shatskaya OA., Kuharenko SS, Drozdova EN, Bondarenko IZ, Tabidze ND et al. Heart failure, diabetes, betablockers and risk of hypoglycemia. Rational pharmacotherapy in cardiology. 2008;4 (3):47-51. DOI:10.20996/1819-6446-2008 -4-3-47-51.

38. Tumulty PA, Mellinkoff SM. The occurrence of hepatic hypoglycemia in congestive heart failure. Trans Am Clin Climatol Assoc. 1952;64:75-82; discussion, 82-3.

39. Mellinkoff SM, Tumulty PA. Hepatic hypoglycemia; its occurrence in congestive heart failure. N Engl J Med. 1952;247 (20):745-50. DOI:10.1056/NEJM195211132472001.

40. Benzing G, Schubert W, Sug G, Kaplan S. Simultaneous hypoglycemia and acute congestive heart failure. Circulation. 1969;40 (2):209-16.

41. Hedayati HA, Beheshti M. Profound spontaneous hypoglycaemia in congestive heart failure. Curr Med Res Opin. 1977;4 (7):501-4. DOI: 10.1185 /03007997709109340.

42. Dungan KM, Osei K, Gaillard T, Moore J, Binkley P. A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation. Diabetes Metab Res Rev. 2015;31 (1):93-101. DOI: 10.1002/dmrr. 2569.

43. Dungan K, Binkley P, Osei K. Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure. J Diabetes Complicat. 2016;30 (1):150-4. DOI:10.1016/j. jdiacomp. 2015.09.009.

44. NICE-SUGAR Study Investigators, Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367 (12):1108-18. DOI: 10.1056/NEJMoa1204942.

45. Pakhetra R, Garg MK, Suryanarayana KM. Management of hyperglycemia in critical illness: review of targets and strategies. Med J Armed Forces India. 2011;67 (1):53-7. DOI:10.1016/S0377-1237 (11) 80015-8.

46. Barsheshet A, Garty M, Grossman E, Sandach A, Lewis BS, Gottlieb S et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med. 2006;166 (15): 1613-9. DOI:10.1001/archinte. 166.15.1613.

47. Adigopula S, Feng Y, Babu V, Parperis KM, Amoateng-Adjepong Y, Zarich S. Hyperglycemia is associated with increased length of stay and total cost in patients hospitalized for congestive heart failure. World Journal of Cardiovascular Diseases. 2013;03 (02):245-9. DOI: 10.4236/wjcd. 2013.32038.

48. Helfand BKI, Maselli NJ, Lessard DM, Yarzebski J, Gore JM, McManus DD et al. Elevated serum glucose levels and survival after acute heart failure: a population-based perspective. Diab Vasc Dis Res. 2015;12 (2):119-25. DOI:10.1177/1479164114559024.

49. OhJ, Kang S-M,Jeon E-S, KimJ-J, Baek SH, Cho M-C et al. The relationship between glucose variability and in-hospital mortality in patients with acute heart failure syndrome: data from the Korean Acute Heart Failure (KorAHF) registry. Journal of Cardiac Failure. 2015;21 (8):S123. DOI:10.1016/j. cardfail. 2015.06.353.

50. Dungan KM, Binkley P, Nagaraja HN, Schuster D, Osei K. The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure. Diabetes Metab Res Rev. 2011;27 (1):85-93. DOI:10.1002/dmrr. 1155.

51. Kosiborod M, Inzucchi SE, Spertus JA, Wang Y, Masoudi FA, Havranek EP et al. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation. 2009; 119 (14):1899-907. DOI: 10.1161 /CIRCULATIONAHA. 108.821843.

52. Lazzeri C, Valente S, Attanà P, Chiostri M, Picariello C, Gensini GF. Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes. Intern Emerg Med. 2012;7 (6):497-503. DOI: 10.1007/s11739-011-0597-4.

53. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32 (6): 1119-31. DOI: 10.2337/dc09-9029.

54. American Diabetes Association. 14. Diabetes Care in the Hospital. Diabetes Care. 2017;40 (Supplement 1):S120-7. DOI:10.2337/ dc17-S017.

55. Dedov II, Shestakova MV, Mayorov AY, Vikulova OK, Galstyan GR, Kuraeva TL et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition. Diabetes mellitus. 2017;20 (1S): 1-112. DOI:10.14341/DM20171S8.

56. Моисеев В. С., Терещенко С. Н., Павликова Е. П., Явелов И. С. Диагностика и лечение острой сердечной недостаточности. Кардиоваскулярная терапия и профилактика. 2006;5 (6 S1):443-72 [Moiseev V. S., Tereshhenko S. N., Pavlikova E. P., Yavelov I. S. Diagnostika i lechenie ostroj serdechnoj nedostatochnosti. Kardiovaskulyarnaya terapiya i profilaktika. 2006;5 (6 S1):443-72].


Для цитирования:


Юрьева М.Ю., Дворяшина И.В. Значение гипергликемии и вариабельности гликемии у пациентов с декомпенсацией хронической сердечной недостаточности в зависимости от выраженности нарушений углеводного обмена. Кардиология. 2017;57(4S):38-46. https://doi.org/ 10.18087/cardio.2403

For citation:


Yuryeva M.Y., Dvoryashina I.V. Prognostic value of glycemic variability in patients with decompensated chronic heart failure and diabetes mellitus. Kardiologiia. 2017;57(4S):38-46. (In Russ.) https://doi.org/ 10.18087/cardio.2403

Просмотров: 52


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0022-9040 (Print)
ISSN 2412-5660 (Online)